Ex vivo biomarker profiling identifies oncostatin-M signaling as spine OA-specific target. (April 2021) - Roessinger, O.; Blanchard, M.; Briki, M.; Jurić, D.; Netzer, C.; Ecker, T.; Hügle, T.; Geurts, J.